Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Ted Bosworth

    News

    Sustained response at 2 years reported for newly approved oral psoriasis agent

    Author:
    Ted Bosworth
    Publish date: September 15, 2022

    Long-term results with the JAK inhibitor for psoriasis show responses persist.

    • Read More

    News

    Targeted anti-IgE therapy found safe and effective for chronic urticaria

    Author:
    Ted Bosworth
    Publish date: September 14, 2022

    Two phase 3 trials associated ligelizumab with efficacy comparable to omalizumab, an approved CSU therapy.

    • Read More

    News

    PARADISE-MI results obscured as post hoc analysis finds flaws

    Author:
    Ted Bosworth
    Publish date: September 14, 2022

    A post hoc analysis of the PARADISE-MI trial suggests relevant benefits are being missed in current trial design.

    • Read More

    News

    Polypodium leucotomos found to reverse AK skin damage

    Author:
    Ted Bosworth
    Publish date: September 9, 2022

    Microscopy at 12 months associated polypodium leucotomos with reversal of skin damage from actinic keratosis.

    • Read More

    News

    AI-assisted reading of echocardiograms readily detects severe aortic stenosis

    Author:
    Ted Bosworth
    Publish date: September 1, 2022

    Moderate and severe aortic stenosis is identified accurately on echocardiograms by artificial intelligence.

    • Read More

    News

    ARBs, beta-blockers independently inhibit Marfan syndrome progression

    Author:
    Ted Bosworth
    Publish date: August 31, 2022

    Compiled data support angiotensin receptor blockers and beta-blockers, alone or together, for Marfan syndrome.

    • Read More

    News

    New ovulatory disorder classifications from FIGO replace 50-year-old system

    Author:
    Ted Bosworth
    Publish date: August 30, 2022

    Once an ovulatory disorder has been diagnosed, four basic categories provide a framework for classification.

    • Read More

    News

    Artificial intelligence poised to change paradigm of CV risk prevention

    Author:
    Ted Bosworth
    Publish date: August 28, 2022

    A new generation causal-based AI algorithm promises to personalize CV risk management to prevent events.

    • Read More

    News

    In blinded trial, artificial intelligence beats sonographers for echo accuracy

    Author:
    Ted Bosworth
    Publish date: August 27, 2022

    In a blinded trial, artificial intelligence provided a more consistent reading of echocardiograms than sonographers.

    • Read More

    News

    Secondary CV prevention benefit from polypill promises global health benefit

    Author:
    Ted Bosworth
    Publish date: August 26, 2022

    In older patients with a prior myocardial infarction, a three-drug polypill significantly reduced risk of CV events in the multinational SECURE...

    • Read More

    News

    Second opinions on melanocytic lesions swayed when first opinion is known

    Author:
    Ted Bosworth
    Publish date: August 24, 2022

    Downward and upward shifts in severity from an accurate diagnosis are concerning because of the likelihood they will lead to overtreatment or...

    • Read More

    News

    How nonadherence complicates cardiology, in two trials

    Author:
    Ted Bosworth
    Publish date: August 15, 2022

    Nonadherence prevents patients from achieving treatment benefits, but it also complicates trial interpretation, suggests subanalyses of MASTER...

    • Read More

    News

    Concerns that low LDL-C alters cognitive function challenged in novel analysis

    Author:
    Ted Bosworth
    Publish date: August 8, 2022

    A Mendelian randomization study appears to exonerate very low LDL-C but not therapies from altering cognition.

    • Read More

    News

    COVID skin manifestations vary by type of variant, U.K. study finds

    Author:
    Ted Bosworth
    Publish date: August 2, 2022

    Omicron and Delta COVID-19 skin manifestations differ, according to large U.K. patient survey.

    • Read More

    News

    Remnant cholesterol captures residual CV risk in patients with T2D

    Author:
    Ted Bosworth
    Publish date: July 29, 2022

    Baseline and follow-up remnant cholesterol levels predict cardiovascular events in patients with type 2 diabetes.

    • Read More

    Pages

    • « first
    • …
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery